![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: GNB1 |
Gene summary for GNB1 |
![]() |
Gene information | Species | Human | Gene symbol | GNB1 | Gene ID | 2782 |
Gene name | G protein subunit beta 1 | |
Gene Alias | MDS | |
Cytomap | 1p36.33 | |
Gene Type | protein-coding | GO ID | GO:0001654 | UniProtAcc | B3KVK2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
2782 | GNB1 | CA_HPV_1 | Human | Cervix | CC | 4.38e-05 | 4.17e-02 | 0.0264 |
2782 | GNB1 | CCI_1 | Human | Cervix | CC | 7.19e-09 | 8.60e-01 | 0.528 |
2782 | GNB1 | CCI_2 | Human | Cervix | CC | 3.76e-10 | 1.40e+00 | 0.5249 |
2782 | GNB1 | CCI_3 | Human | Cervix | CC | 5.07e-22 | 1.29e+00 | 0.516 |
2782 | GNB1 | HTA11_2487_2000001011 | Human | Colorectum | SER | 1.06e-03 | 5.82e-01 | -0.1808 |
2782 | GNB1 | HTA11_1938_2000001011 | Human | Colorectum | AD | 4.37e-05 | 5.78e-01 | -0.0811 |
2782 | GNB1 | HTA11_347_2000001011 | Human | Colorectum | AD | 1.30e-13 | 6.90e-01 | -0.1954 |
2782 | GNB1 | HTA11_411_2000001011 | Human | Colorectum | SER | 6.45e-07 | 9.30e-01 | -0.2602 |
2782 | GNB1 | HTA11_696_2000001011 | Human | Colorectum | AD | 5.12e-04 | 4.57e-01 | -0.1464 |
2782 | GNB1 | HTA11_1391_2000001011 | Human | Colorectum | AD | 9.13e-07 | 7.40e-01 | -0.059 |
2782 | GNB1 | HTA11_99999965062_69753 | Human | Colorectum | MSI-H | 1.05e-10 | 1.06e+00 | 0.3487 |
2782 | GNB1 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 1.46e-04 | 6.52e-01 | 0.3859 |
2782 | GNB1 | F007 | Human | Colorectum | FAP | 9.00e-06 | -4.33e-01 | 0.1176 |
2782 | GNB1 | A002-C-010 | Human | Colorectum | FAP | 1.28e-06 | -2.85e-01 | 0.242 |
2782 | GNB1 | A001-C-207 | Human | Colorectum | FAP | 3.57e-04 | -2.39e-01 | 0.1278 |
2782 | GNB1 | A015-C-203 | Human | Colorectum | FAP | 1.23e-32 | -4.03e-01 | -0.1294 |
2782 | GNB1 | A015-C-204 | Human | Colorectum | FAP | 1.92e-06 | -3.27e-01 | -0.0228 |
2782 | GNB1 | A014-C-040 | Human | Colorectum | FAP | 1.45e-05 | -3.76e-01 | -0.1184 |
2782 | GNB1 | A002-C-201 | Human | Colorectum | FAP | 9.74e-16 | -3.00e-01 | 0.0324 |
2782 | GNB1 | A002-C-203 | Human | Colorectum | FAP | 1.71e-07 | -2.53e-01 | 0.2786 |
Page: 1 2 3 4 5 6 7 8 9 10 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00072656 | Cervix | CC | Ras protein signal transduction | 79/2311 | 337/18723 | 9.49e-09 | 7.77e-07 | 79 |
GO:190165410 | Cervix | CC | response to ketone | 45/2311 | 194/18723 | 1.83e-05 | 3.44e-04 | 45 |
GO:000166610 | Cervix | CC | response to hypoxia | 61/2311 | 307/18723 | 1.04e-04 | 1.34e-03 | 61 |
GO:007048210 | Cervix | CC | response to oxygen levels | 67/2311 | 347/18723 | 1.21e-04 | 1.51e-03 | 67 |
GO:003629310 | Cervix | CC | response to decreased oxygen levels | 62/2311 | 322/18723 | 2.29e-04 | 2.57e-03 | 62 |
GO:00714539 | Cervix | CC | cellular response to oxygen levels | 38/2311 | 177/18723 | 4.23e-04 | 4.27e-03 | 38 |
GO:00362949 | Cervix | CC | cellular response to decreased oxygen levels | 35/2311 | 161/18723 | 5.49e-04 | 5.29e-03 | 35 |
GO:00714566 | Cervix | CC | cellular response to hypoxia | 33/2311 | 151/18723 | 7.06e-04 | 6.41e-03 | 33 |
GO:00973059 | Cervix | CC | response to alcohol | 46/2311 | 253/18723 | 4.40e-03 | 2.69e-02 | 46 |
GO:0150063 | Cervix | CC | visual system development | 63/2311 | 375/18723 | 6.58e-03 | 3.65e-02 | 63 |
GO:0001654 | Cervix | CC | eye development | 62/2311 | 371/18723 | 7.83e-03 | 4.13e-02 | 62 |
GO:0048880 | Cervix | CC | sensory system development | 63/2311 | 381/18723 | 9.29e-03 | 4.66e-02 | 63 |
GO:1905144 | Cervix | CC | response to acetylcholine | 9/2311 | 31/18723 | 1.04e-02 | 4.97e-02 | 9 |
GO:1905145 | Cervix | CC | cellular response to acetylcholine | 9/2311 | 31/18723 | 1.04e-02 | 4.97e-02 | 9 |
GO:0007265 | Colorectum | AD | Ras protein signal transduction | 104/3918 | 337/18723 | 1.01e-05 | 2.35e-04 | 104 |
GO:0070482 | Colorectum | AD | response to oxygen levels | 99/3918 | 347/18723 | 4.29e-04 | 4.82e-03 | 99 |
GO:0071453 | Colorectum | AD | cellular response to oxygen levels | 55/3918 | 177/18723 | 9.48e-04 | 8.96e-03 | 55 |
GO:1901654 | Colorectum | AD | response to ketone | 59/3918 | 194/18723 | 1.14e-03 | 1.04e-02 | 59 |
GO:0001666 | Colorectum | AD | response to hypoxia | 86/3918 | 307/18723 | 1.77e-03 | 1.46e-02 | 86 |
GO:0036293 | Colorectum | AD | response to decreased oxygen levels | 88/3918 | 322/18723 | 3.42e-03 | 2.49e-02 | 88 |
Page: 1 2 3 4 5 6 7 8 9 10 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0516312 | Liver | Cirrhotic | Human cytomegalovirus infection | 87/2530 | 225/8465 | 2.67e-03 | 1.10e-02 | 6.76e-03 | 87 |
hsa0516714 | Liver | Cirrhotic | Kaposi sarcoma-associated herpesvirus infection | 73/2530 | 194/8465 | 1.17e-02 | 3.81e-02 | 2.35e-02 | 73 |
hsa0472314 | Liver | Cirrhotic | Retrograde endocannabinoid signaling | 57/2530 | 148/8465 | 1.45e-02 | 4.39e-02 | 2.71e-02 | 57 |
hsa0516313 | Liver | Cirrhotic | Human cytomegalovirus infection | 87/2530 | 225/8465 | 2.67e-03 | 1.10e-02 | 6.76e-03 | 87 |
hsa0516715 | Liver | Cirrhotic | Kaposi sarcoma-associated herpesvirus infection | 73/2530 | 194/8465 | 1.17e-02 | 3.81e-02 | 2.35e-02 | 73 |
hsa0472315 | Liver | Cirrhotic | Retrograde endocannabinoid signaling | 57/2530 | 148/8465 | 1.45e-02 | 4.39e-02 | 2.71e-02 | 57 |
hsa051709 | Liver | HCC | Human immunodeficiency virus 1 infection | 125/4020 | 212/8465 | 4.51e-04 | 1.94e-03 | 1.08e-03 | 125 |
hsa0516322 | Liver | HCC | Human cytomegalovirus infection | 131/4020 | 225/8465 | 6.86e-04 | 2.77e-03 | 1.54e-03 | 131 |
hsa0516721 | Liver | HCC | Kaposi sarcoma-associated herpesvirus infection | 111/4020 | 194/8465 | 3.78e-03 | 1.16e-02 | 6.45e-03 | 111 |
hsa049262 | Liver | HCC | Relaxin signaling pathway | 75/4020 | 129/8465 | 9.33e-03 | 2.46e-02 | 1.37e-02 | 75 |
hsa0517012 | Liver | HCC | Human immunodeficiency virus 1 infection | 125/4020 | 212/8465 | 4.51e-04 | 1.94e-03 | 1.08e-03 | 125 |
hsa0516332 | Liver | HCC | Human cytomegalovirus infection | 131/4020 | 225/8465 | 6.86e-04 | 2.77e-03 | 1.54e-03 | 131 |
hsa0516731 | Liver | HCC | Kaposi sarcoma-associated herpesvirus infection | 111/4020 | 194/8465 | 3.78e-03 | 1.16e-02 | 6.45e-03 | 111 |
hsa0492611 | Liver | HCC | Relaxin signaling pathway | 75/4020 | 129/8465 | 9.33e-03 | 2.46e-02 | 1.37e-02 | 75 |
hsa0516729 | Oral cavity | OSCC | Kaposi sarcoma-associated herpesvirus infection | 125/3704 | 194/8465 | 3.67e-09 | 3.84e-08 | 1.96e-08 | 125 |
hsa0517027 | Oral cavity | OSCC | Human immunodeficiency virus 1 infection | 133/3704 | 212/8465 | 1.42e-08 | 1.40e-07 | 7.12e-08 | 133 |
hsa0516328 | Oral cavity | OSCC | Human cytomegalovirus infection | 139/3704 | 225/8465 | 2.77e-08 | 2.38e-07 | 1.21e-07 | 139 |
hsa041516 | Oral cavity | OSCC | PI3K-Akt signaling pathway | 185/3704 | 354/8465 | 6.26e-04 | 1.86e-03 | 9.49e-04 | 185 |
hsa049267 | Oral cavity | OSCC | Relaxin signaling pathway | 74/3704 | 129/8465 | 1.20e-03 | 3.37e-03 | 1.72e-03 | 74 |
hsa05167113 | Oral cavity | OSCC | Kaposi sarcoma-associated herpesvirus infection | 125/3704 | 194/8465 | 3.67e-09 | 3.84e-08 | 1.96e-08 | 125 |
Page: 1 2 3 4 5 6 7 8 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
GNB1 | SNV | Missense_Mutation | c.806N>C | p.Ile269Thr | p.I269T | P62873 | protein_coding | deleterious(0) | probably_damaging(0.984) | TCGA-BH-A0HN-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | arimidex | SD | |
GNB1 | insertion | Frame_Shift_Ins | novel | c.644_645insTTAC | p.Glu215AspfsTer15 | p.E215Dfs*15 | P62873 | protein_coding | TCGA-B6-A0IK-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | PD | ||
GNB1 | SNV | Missense_Mutation | novel | c.283N>G | p.Leu95Val | p.L95V | P62873 | protein_coding | deleterious(0.01) | possibly_damaging(0.566) | TCGA-EA-A3Y4-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
GNB1 | SNV | Missense_Mutation | novel | c.208N>G | p.Leu70Val | p.L70V | P62873 | protein_coding | tolerated(0.12) | benign(0.061) | TCGA-VS-A94Z-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
GNB1 | SNV | Missense_Mutation | c.287G>A | p.Arg96His | p.R96H | P62873 | protein_coding | tolerated(0.06) | benign(0.117) | TCGA-A6-6781-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | SD | |
GNB1 | SNV | Missense_Mutation | c.946N>G | p.Ser316Gly | p.S316G | P62873 | protein_coding | deleterious(0) | probably_damaging(0.991) | TCGA-AA-3845-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
GNB1 | SNV | Missense_Mutation | novel | c.1001N>T | p.Ser334Ile | p.S334I | P62873 | protein_coding | deleterious(0.05) | probably_damaging(0.919) | TCGA-AA-3966-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
GNB1 | SNV | Missense_Mutation | novel | c.785N>C | p.Met262Thr | p.M262T | P62873 | protein_coding | tolerated(0.57) | benign(0.003) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
GNB1 | SNV | Missense_Mutation | c.688N>T | p.Asn230Tyr | p.N230Y | P62873 | protein_coding | deleterious(0) | possibly_damaging(0.857) | TCGA-EI-6882-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
GNB1 | SNV | Missense_Mutation | novel | c.514G>A | p.Glu172Lys | p.E172K | P62873 | protein_coding | deleterious(0.02) | probably_damaging(0.989) | TCGA-F5-6814-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |